Advanced Search

Clinical Trial Product Stocks List

Symbol Grade Name % Change
BIIB F Biogen Idec Inc. -0.15
HALO C Halozyme Therapeutics, Inc. 3.30
IMGN D ImmunoGen, Inc. 4.81
INCY D Incyte Corporation 1.93
LGND D Ligand Pharmaceuticals Incorporated 2.74
SUPN A Supernus Pharmaceuticals, Inc. 1.85
HCM D Hutchison China MediTech Limited -1.48
LBPH F Longboard Pharmaceuticals, Inc. 2.45
View As Page of Charts
Related Industries: Biotechnology Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic
Related Stock Lists: Biotechnology Solid Tumors Biopharmaceutical Chronic Lymphocytic Leukemia Lymphocytic Leukemia Monoclonal Antibodies Alzheimer's Disease Chemical Compounds Clinical Trial Clinical Trial Products Drug Discovery Epilepsy Lymphoma Multiple Myeloma Neurology Non Small Cell Lung Cancer Organic Compounds Pain Pharmaceutical Industry Psoriasis

Related ETFs - A few ETFs which own one or more of the above listed Clinical Trial Product stocks.

Symbol Grade Name Weight
DWSH F AdvisorShares Dorsey Wright Short ETF 74.8
BBP D BioShares Biotechnology Products Fund 9.98
BIS D ProShares UltraShort Nasdaq Biotechnology 9.05
PJP D PowerShares Dynamic Pharmaceuticals 8.9
BBH C Market Vectors Biotech ETF 7.99
View all Clinical Trial Product related ETFs...
Compare ETFs
  • Compare BIS to PJP
  • Compare DWSH to PJP
  • Compare PJP to BBH

    • Recent Signals

    Date Stock Signal Type
    2021-04-14 BIIB 200 DMA Resistance Bearish
    2021-04-14 BIIB 180 Bearish Setup Bearish Swing Setup
    2021-04-14 HALO Crossed Above 50 DMA Bullish
    2021-04-14 HALO Stochastic Reached Overbought Strength
    2021-04-14 HALO Expansion Pivot Buy Setup Bullish Swing Setup
    2021-04-14 HALO Pocket Pivot Bullish Swing Setup
    2021-04-14 HCM NR7 Range Contraction
    2021-04-14 HCM Upper Bollinger Band Walk Strength
    2021-04-14 HCM Bollinger Band Squeeze Range Contraction
    2021-04-14 HCM Bearish Engulfing Bearish
    2021-04-14 HCM NR7-2 Range Contraction
    2021-04-14 HCM Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
    2021-04-14 IMGN Slingshot Bearish Bearish Swing Setup
    2021-04-14 IMGN Lower Bollinger Band Walk Weakness
    2021-04-14 INCY Crossed Above 20 DMA Bullish
    2021-04-14 INCY Crossed Above 50 DMA Bullish
    2021-04-14 LBPH Lower Bollinger Band Walk Weakness
    2021-04-14 LGND 20 DMA Resistance Bearish
    2021-04-14 SUPN Upper Bollinger Band Walk Strength
    2021-04-14 SUPN Stochastic Reached Overbought Strength
    2021-04-14 SUPN Calm After Storm Range Contraction
    2021-04-14 SUPN Doji - Bearish? Reversal
    2021-04-14 SUPN New 52 Week High Strength
    2021-04-14 SUPN New 52 Week Closing High Bullish

    Recent News for Clinical Trial Product Stocks

    Date Stock Title
    Apr 14 BIIB Biogen to Present Trial Design of Aducanumab EMBARK Re-Dosing Study in Poster Session at 2021 Virtual AAN Annual Meeting on April 17-22, 2021
    Apr 14 LBPH 22 Stocks Moving in Wednesday's Pre-Market Session
    Apr 13 BIIB Sage (SAGE), Biogen Report Positive Data on Essential Tremor Study
    Apr 13 SUPN Supernus approaches LOE for Trokendi, but Jefferies sees ‘a new product cycle’
    Apr 13 SUPN IRhythm extends losses as more downgrades pile up, Aphria cut to neutral after earnings miss; and more in today’s analyst action
    Apr 13 INCY Incyte to Report First Quarter Financial Results
    Apr 12 BIIB Neurology Drug Study Does Little for Sage Therapeutics, or Its Partner Biogen
    Apr 12 INCY Incyte Corporation (INCY) Presents at AACR Virtual Meeting 2021 - Slideshow
    Apr 12 BIIB Biogen and Sage trade lower despite positive essential tremor trial
    Apr 12 BIIB Sage-Biogen Essential Tremor Candidate Hits Primary Endpoint Goal, But 38% Of People Drop Out
    Apr 12 BIIB Sage Stock Trips As Analysts Question Longevity Of Biogen-Partnered Drug
    Apr 12 BIIB Sage Therapeutics/Biogen's SAGE-324 meets primary endpoint in essential tremor study
    Apr 12 BIIB Sage Therapeutics and Biogen Announce SAGE-324 Phase 2 Placebo-Controlled KINETIC Study in Essential Tremor Met Primary Endpoint
    Apr 10 IMGN ImmunoGen Presents Preclinical Data on IMGC936 at the AACR Virtual Annual Meeting
    Apr 9 BIIB Biogen Announces Two New Nominees for Election to Board of Directors
    Apr 9 INCY Seeking Alpha Catalyst Watch
    Apr 9 INCY Lilly's (LLY) JAK Inhibitor Olumiant Fails COVID-19 Study
    Apr 9 BIIB Provention Bio downgraded on FDA feedback, Citi sizes up Zuranolone success on Sage, and more in today’s analyst action
    Apr 9 INCY Provention Bio downgraded on FDA feedback, Citi sizes up Zuranolone success on Sage, and more in today’s analyst action
    Apr 8 BIIB Biotech Stocks Could Use A Win — Will The First Quarter Offer That?
    Related Industries: Biotechnology Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic
    Related Stock Lists: Biotechnology Solid Tumors Biopharmaceutical Chronic Lymphocytic Leukemia Lymphocytic Leukemia Monoclonal Antibodies Alzheimer's Disease Chemical Compounds Clinical Trial Clinical Trial Products Drug Discovery Epilepsy Lymphoma Multiple Myeloma Neurology Non Small Cell Lung Cancer Organic Compounds Pain Pharmaceutical Industry Psoriasis

    Browse All Tags